In 2017, the North America chromatography resins market was valued at USD 692.20 million. The market is expected to register a CAGR of nearly 6.21% during 20182023 the forecast period. The United States accounted for the largest share, accounting for more than 85% of the regional market, while Mexico is anticipated to register the fastest CAGR over the forecast period, 20182023.
Significant Growth in Demand for Chromatography Tests, as a Part of Drug Approvals
Over the last two decades, the major characteristic, supporting the development in the methodology of pharmaceutical and biomedical analysis, is that the chromatography has become the most important analytical method for identification, quantification, and testing of drugs, either in its active pharmaceutical ingredient or formulations during the process of the discovery, development, testing, and manufacturing. The United States has the most stringent standards for approving new drugs. The demand for the US drug approval standards is high throughout the world. Similar to these requirements, there are two regulatory steps to go through before a drug is approved in the European Union. These two steps are clinical trial application and marketing authorization application. These factors are likely to boost the demand for chromatography resins.
Pharmaceuticals to Dominate the North American Market
The utility in separation and analysis of biomolecules, based on the biological functions or individual structures in the pharmaceutical industry biotechnology, is growing in popularity. The advancement in recombinant DNA technology in the biotechnology industry have led to the discovery of techniques for isolating the genes for individual proteins, expressing these proteins in microbial or mammalian cell culture and recovering the heterologous protein in active form. Chromatography requires highscale usage of chromatography resins. Chromatography resin is one of the major contributors to the cost of goods for the production of a biotechnology therapeutic. Currently, in terms of consumption, North America is the leader of chromatography resins in biotechnology applications. North American countries are spending heavily in RD activities to get advanced in the field of biotechnology.
Mexico to Expand at the Fastest Rate
In North America, Mexico has the secondlargest pharmaceutical industry. It is one of the major producers of advanced medicines, such as antiinflammatory drugs, antibiotics, etc. The growing population, along with the rising level of exports in the Latin American market, has boosted the pharmaceutical industry in this region. Chromatographic resin finds a major usage in the food processing industry. Mexico has the secondlargest food processing industry in North America and eighth largest in the world.
Key Developments in the Market
September 2017: Thermo Fisher Scientific Inc. launched PureLink Fast LowEndotoxin Plasmid Purification Midi and Maxi Kits, which is used in to accelerate the process of isolation of plasmid DNA
March 2017: Tosoh Bioscience launched TOYOPEARL AFrProtein L650F, a protein L resin that exhibits highbinding capacity
Major Players: THERMO FISHER SCIENTIFIC INC., MERCK KGAA, TOSOH BIOSCIENCE LLC, BIORAD LABORATORIES, INC., PALL CORPORATION, AVANTOR PERFORMANCE MATERIALS, LLC, amongst others.
Reasons to Purchase this Report
Role of the pharmaceutical industry in the market growth
Various market perspectives, with the help of Porter's five forces analysis
Dominating application and technology during the forecast period
The fast growing countries during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
3 months analyst support, along with the Market Estimate sheet in excel.
Customization of the Report
This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.